Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma.

被引:0
|
作者
Lucas, John Thomas
Wakefield, Daniel Victor
Doubrovin, Michael
Li, Yimei
Cooper, David
Manole, Bogdan-Alexandru
Santiago, Teresa
Federico, Sara Michele
Merchant, Thomas E.
Davidoff, Andrew M.
Krasin, Matthew J.
Shulkin, Barry L.
Santana, Victor M.
Furman, Wayne Lee
机构
[1] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
关键词
D O I
10.1200/JCO.2017.35.15_suppl.10557
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10557
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma
    Lucas, John Thomas, Jr.
    Wakefield, Daniel Victor
    Doubrovin, Michael
    Li, Yimei
    Santiago, Teresa
    Federico, Sara Michele
    Merchant, Thomas E.
    Davidoff, Andrew M.
    Krasin, Matthew J.
    Shulkin, Barry L.
    Santana, Victor M.
    Furman, Wayne Lee
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 34 : 42 - 50
  • [2] Outcome in patients with refractory high-risk neuroblastoma.
    Siddiqui, Amir Bari
    Oppong, Akosua
    Yuan, Cindy
    Gao, Guimin
    Bagatell, Rochelle
    Berg, Katherine
    Sokol, Elizabeth
    MacQuarrie, Kyle
    Pinto, Navin R.
    Gollapudi, Anurekha
    Mody, Rajen
    Wolfe, Ian
    Shusterman, Suzanne
    Foster, Jennifer
    Smith, Valeria
    Cohn, Susan Lerner
    Desai, Ami Vijay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Allogeneic transplantation for patients with high-risk or refractory neuroblastoma.
    Driscoll, T. A.
    Martin, P. L.
    Moffet, J.
    Daniel, M.
    Page, K.
    Parikh, S.
    Prasad, V.
    Szabolcs, P.
    Kurtzberg, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Patterns of Failure in High-Risk Neuroblastoma with or without Metastatic Site Irradiation
    Aliru, M. L.
    Chapman, J. T.
    Montalvo, S. K.
    Dan, T.
    Watt, T. C.
    Kumar, K. A., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E487 - E487
  • [5] Patterns of relapse after immunotherapy in patients with high-risk neuroblastoma.
    Moerdler, Scott
    Naranjo, Arlene
    Tenney, Sheena
    Bagatell, Rochelle
    Yu, Alice L.
    London, Wendy B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Role of MIBG Studies in Prognostication and Prediction of Metastatic Site Failure in Pediatric Patients with High-Risk Neuroblastoma
    Wakefield, D. V.
    Lucas, J. T., Jr.
    Li, Y.
    Cooper, D. A.
    Manole, B. A.
    Merchant, T. E.
    Davidoff, A. M.
    Krasin, M.
    Santana, V. M.
    Furman, W. L.
    Shulkin, B. L.
    Doubrovin, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S27 - S28
  • [7] Validation of postinduction Curie scores in high-risk neuroblastoma.
    Yanik, Gregory A.
    Naranjo, Arlene
    Parisi, Marguerite T.
    Shulkin, Barry L.
    Nadel, Helen R.
    Gelfand, Michael J.
    Ladenstein, Ruth L.
    Boubaker, Ariane
    Poetschger, Ulrike
    Lambert, Bieke
    Castellani, Maria Rita
    Valteau-Couanet, Dominique
    Kreissman, Susan G.
    Park, Julie R.
    Matthay, Katherine K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Gene expression analysis for improved subtyping of high-risk neuroblastoma.
    Pfeil, Jacob
    Thornton, Alexis
    Durbin, Ann
    Kephart, Ellen
    Beale, Holly
    Sanders, Lauren
    Bjork, Isabel
    Morozova, Olena
    Salama, Sofie R.
    Haussler, David
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Inhibition of Exportin-1 as part of combinatorial treatment for patients with high-risk neuroblastoma.
    Galinski, Basia
    Landesman, Yossef
    Weiser, Daniel
    CANCER RESEARCH, 2021, 81 (13)
  • [10] CHARACTERIZATION OF HIGH RISK NEUROBLASTOMA. POTENTIAL BIOMARKERS FOR STRATIFICATION OF HIGH RISK NEUROBLASTOMA
    Garrido, Alicia
    Perez, Sara
    Garcia, Marta
    Garcia, Laura
    Lemos, Isadora
    Rodriguez, Eva
    Aznar, Oscar Munoz
    Sunol, Mariona
    Gomez-Gonzalez, Soledad
    Lavarino, Cinzia
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S216 - S217